The La Jolla Institute for Allergy and Immunology announced Monday an official affiliation agreement with the University of California, San Diego Health System.
The agreement formalizes an informal, decades-old relationship built on shared research interests and a long history of successful scientific collaboration, the university said.
“For many years, we have enjoyed a cordial and mutually beneficial relationship with UCSD,” said Mitchell Kronenberg, Ph.D., president and chief scientific officer of the La Jolla Institute. “The reinforcement of our longstanding relationship through a formal agreement is a transformative step for both institutions.”
The multi-year agreement with UCSD will facilitate joint faculty appointments, enhance the range and depth of collaboration between the two organizations, and promote closer integration between basic immunology research and clinical medicine to speed the development of treatments for diseases of the immune system.
The agreement with UCSD will align the Institute’s cutting-edge, fundamental research on the immune system with a world-class, research-focused medical school and hospital system.
“Scientists at both institutions have been very adept at making connections through informal channels,” said David Brenner, vice chancellor at UC San Diego Health Sciences and dean of the School of Medicine. “With a formal agreement in place, we can be strategic about strengthening immunology research on the Torrey Pines mesa. Without doubt, the close integration of scientists at LJI and UC San Diego with UC San Diego Health clinicians will spark innovation and allow us to deliver pioneering immune-based treatments and therapeutics to patients in the clinic.”